StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.51−0.02 (-1.31%)

Close on Nov 13, 2026Market cap $850.64KP/E –Yield –

Universe Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 35.3%, against 26.4% the year before. The highest annual figure on record is 54.5% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 202535.3%+8.9
FY2024Sep 30, 202426.4%−5.6
FY2023Sep 30, 202331.9%−22.6
FY2022Sep 30, 202254.5%+1.8
FY2021Sep 30, 202152.8%+6.9
FY2020Sep 30, 202045.9%+5.6
FY2019Sep 30, 201940.3%–

More Universe Pharmaceuticals figures

See a number that looks wrong?